Base Editing vs. Prime Editing

Introduction

In the early 2010s, CRISPR transformed genetic research and quickly became a dominant tool in life sciences. As research progressed, newer techniques emerged to address some of its limitations. Two major developments, base editing and prime editing, were pioneered in the lab of David Liu. These approaches aim to make gene editing more precise while avoiding some of the challenges associated with traditional CRISPR methods.

---

Base Editing

First described in 2016, base editing enables scientists to change a single DNA letter without creating double-strand breaks in the DNA. Traditional CRISPR methods rely on cutting both strands of DNA and allowing the cell to repair the damage. In contrast, base editing directly converts one base into another at a targeted location.

This system uses a modified version of the Cas9 enzyme that no longer cuts DNA. Instead, it is fused to a base-modifying enzyme. Guided by RNA, the complex binds to a specific DNA sequence, where the enzyme chemically changes one nucleotide into another without breaking the DNA backbone.

Base editing allows precise single-letter substitutions, such as converting one base pair into another, without causing insertions or deletions. Because it avoids double-strand breaks, it lowers the risk of unintended mutations. This makes it particularly useful for correcting point mutations linked to genetic diseases. However, its main limitation is that only certain types of point mutations can currently be altered using this method.

---

Prime Editing

Introduced in 2019, prime editing is often described as a “search-and-replace” system for DNA. Like base editing, it avoids creating double-strand breaks. However, it offers greater flexibility in the types of edits it can perform.

Prime editing combines a modified Cas9 enzyme (called a nickase) with a reverse transcriptase enzyme and a specialized RNA molecule known as prime editing guide RNA (pegRNA). The nickase makes a single-strand cut in the DNA, and the pegRNA provides a template that specifies the desired genetic change.

The reverse transcriptase then builds a new DNA segment using this template. Finally, the cell’s repair machinery integrates the edited sequence into the genome. Unlike base editing, prime editing can introduce insertions, deletions, and a wider range of substitutions, expanding its potential applications.

---

Real-World Application: Sickle Cell Disease

A major example of prime editing’s potential involves sickle cell disease, a serious blood disorder caused by a single mutation in the haemoglobin-Beta gene. The disease results from one adenine-to-thymine substitution.

Earlier studies showed that base editing could replace the harmful mutation with a benign variant, but it could not fully restore the original healthy DNA sequence. Prime editing, however, successfully corrected the mutation in 40% of patient-derived stem cells in one study. Follow-up experiments in mice suggested the possibility of long-term therapeutic benefits, highlighting the technique’s clinical promise.

---

What Comes Next?

Although both methods represent significant advances, neither is perfect. Further refinement is required before widespread human use becomes possible. Researchers at the Broad Institute are continuing to improve these tools, with hopes that prime editing may soon enter human clinical trials.

While base and prime editing offer advantages over CRISPR in certain contexts, CRISPR itself is still developing. Each technology has a distinct role in the expanding gene-editing toolbox. As research continues, these methods will likely complement rather than replace one another, contributing to safer and more precise genetic medicine.

References

1. Front Line Genomics, & Fletcher, L. (2024, February 28). Back to Basics - Base & Prime Editing - Front Line Genomics. Front Line Genomics. https://frontlinegenomics.com/back-to-basics-base-and-prime-editing/

Assessed and Endorsed by the MedReport Medical Review Board